glp 1 tachycardia GLP-1s and Tachycardia: What Patients Need to Know, A modest increase in resting heart rate has been observed with GLP-1 receptor agonists and dual GIP/GLP-1 agonists such as Wegovy, Ozempic, and Frontiers | Clinical perspectives on

Asking about lifestyle habits also helps to ensure the medication fits into the patients health journey

Soluble fiber slows gastric emptying and increases incretin hormone release, mimicking GLP-1's digestive effects

Taking GLP-1s appears to alter these areas and change the levels of reward-related neurotransmitters dopamine and glutamate, a review of related studies suggests

As of 2026 there is no FDA-approved cagrilintide + tirzepatide product and no dedicated human combination trial

Its been tested in multiple double-blind RCTs for visceral fat reduction and is FDA-approved to reduce visceral fat in HIV-associated lipodystrophy